EUVIMEDEUVIMED entdecken
Crossref

Conditional Survival of Gallbladder Cancer After Curative‐Intent Surgery: Impact of Disease Stage, Surgical Extent, and Adjuvant Therapy

Hyeong Seok Kim iD, Danbee Kang, Hea Lim Choi iD, Hong Kwan Kim, Sang Hyun Shin iD, In Woong Han iD, Jin Seok Heo, Dong Wook Shin iD, Hongbeom Kim iD

Journal of Hepato-Biliary-Pancreatic Sciences · 05.11.2026

DOI: 10.1002/jhbp.70210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 05.11.2026. Verfasst von Hyeong Seok Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, S…. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gallbladder cancer is a rare but aggressive malignancy with poor prognosis even after curative‐intent surgery. Conventional survival estimates provide fixed probabilities from diagnosis and fail to reflect the evolving prognosis of patients who have already survived several years. Conditional survival (CS) offers time‐updated prognostic information, but evidence in gallbladder cancer remains limited.

Methods

We retrospectively analyzed 641 patients who underwent curative‐intent resection for gallbladder cancer at a tertiary referral center (2005–2019). Five‐year conditional overall survival (COS) and conditional recurrence‐free survival were estimated up to 5 years postoperatively. Analyses were stratified by age, stage, comorbidity, surgical extent, and adjuvant therapy.

Results

Baseline 5‐year COS was 69.4% and increased to 74.0% among patients surviving 5 years. Stage III patients showed the largest improvement (45.9%–69.4%), whereas Stage I patients remained stable. In Stage II–III disease, extended cholecystectomy was associated with improved COS (63.2%–74.3%), while simple cholecystectomy showed a decline (65.7%–48.0%). Adjuvant therapy was associated with greater COS improvement (50.4%–69.2%) than no adjuvant therapy. Older patients (≥ 70 years) and those with diabetes showed poorer outcomes.

Conclusion

CS provides a dynamic framework for prognostication in gallbladder cancer and may support risk‐stratified follow‐up.

Schlagwörter

Stichwörter der Autor:innen

Koreaconditional survivalgallbladder cancerprognosisrelative survival

Autor:innen und Institutionen

  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Department of Clinical Research Design and Evaluation, The Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.
  • Trend Sensing & Risk Modeling Center, Institution of Cancer Quality of Life, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Department of Family Medicine/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

ORCID-Profile: Hyeong Seok Kim, Hea Lim Choi, Sang Hyun Shin, In Woong Han, Dong Wook Shin, Hongbeom Kim

Förderung

  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Kim, H. S., Kang, D., Choi, H. L., Kim, H. K., Shin, S. H., Han, I. W., Heo, J. S., Shin, D. W., & Kim, H. (2026). Conditional Survival of Gallbladder Cancer After Curative‐Intent Surgery: Impact of Disease Stage, Surgical Extent, and Adjuvant Therapy. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70210

Vancouver

Kim HS, Kang D, Choi HL, Kim HK, Shin SH, Han IW, et al. Conditional Survival of Gallbladder Cancer After Curative‐Intent Surgery: Impact of Disease Stage, Surgical Extent, and Adjuvant Therapy. Journal of Hepato-Biliary-Pancreatic Sciences. 2026. doi:10.1002/jhbp.70210

BibTeX
@article{Kim2026,
  author = {Kim, Hyeong Seok and Kang, Danbee and Choi, Hea Lim and Kim, Hong Kwan and Shin, Sang Hyun and Han, In Woong and Heo, Jin Seok and Shin, Dong Wook and Kim, Hongbeom},
  title = {Conditional Survival of Gallbladder Cancer After Curative‐Intent Surgery: Impact of Disease Stage, Surgical Extent, and Adjuvant Therapy},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2026},
  doi = {10.1002/jhbp.70210}
}
Kostenlos starten →